The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Clinical Benefits of Antiviral Therapy in Patients with Recurrent Hepatitis C Following Liver Transplantation
Open accessAbstract
Pegylated interferon (pegIFN) and ribavirin eradicates hepatitis C virus (HCV) in one third of liver recipients with recurrent disease. Side effects are frequent and potentially life threatening. Our aim was to define the long-term benefits of antiviral therapy in recurrent HCV. Eighty-nine (89) recipients (genotype 1: 86.5%) were treated with IFN (n = 31) or pegIFN (n = 58) plus ribavirin and 75 untreated contemporaneous disease-matched controls. The major end point was survival from transplantation. Survival, progression to cirrhosis and clinical decompensation since start of therapy were compared between sustained virologic responders (SVRs) and nonresponders (NRs). Results revealed 44 patients died during the follow-up (20% treated vs. 35% controls; p = 0.05). Patient survival was higher in treated compared to controls (7 years: 74% vs. 62%; p = 0.04). Among treated patients, an SVR was achieved in 37% (IFN 16% vs. peg-IFN 48%; p = 0.03). About 2/33 SVRs and 16/56 NRs died (p = 0.01) due to HCV-disease (56%), IFN-induced rejection (11%), both causes (11%) or others (22%). Five-year survival was greater in SVRs than in NRs (93% vs. 69%, p = 0.032). In patients without baseline cirrhosis, progression to cirrhosis occurred more frequently in NRs (27/42 vs. 6/16; p = 0.06). The 5-year risk of graft decompensation was higher in NRs (33% vs. 16%; p = 0.04). Antiviral therapy is associated with improved long-term outcome in recurrent HCV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prieto, M., Berenguer, M., Rayón, J. M., Córdoba, J., Argüello, L., Carrasco, D., García-Herola, A., Olaso, V., De Juan, M., Gobernado, M., et al. (1999) · Hepatology · doi:10.1002/hep.510290122 · Cited by 537
Self-citationWiesner, R. H., Sorrell, M., & Villamil, F. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50268 · Cited by 442
Carrión, J. A., Navasa, M., García-Retortillo, M., García‐Pagán, J. C., Crespo, G., Bruguera, M., Bosch, J., & Forns, X. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.041 · Cited by 347
Hepatitis C and liver transplantation
Berenguer, M., López-Labrador, F. X., & Wright, T. L. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00179-9 · Cited by 284
Self-citationPicciotto, F. P., Tritto, G., Lanza, A. G., Addario, L., De Luca, M., Di Costanzo, G., Lampasi, F., Tartaglione, M. T., Marsilia, G. M., Calise, F., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.10.017 · Cited by 195
Wang, C. S., Ko, H. H., Yoshida, E. M., Marra, C. A., & Richardson, K. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01362.x · Cited by 193
Report of the Monothematic EASL Conference on Liver Transplantation for Viral Hepatitis
Samuel, D., Forns, X., Berenguer, M., Trautwein, C., Burroughs, A., Rizzetto, M., & Trepo, C. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.001 · Cited by 161
Self-citationBizollon, T., Ahmed, S. N. S., Radenne, S., Chevallier, M., Chevallier, P., Parvaz, P., Guichard, S., Ducerf, C., Baulieux, J., Zoulim, F., et al. (2003) · Gut · doi:10.1136/gut.52.2.283 · Cited by 160
Firpi, R. J., Abdelmalek, M. F., Soldevila‐Pico, C., Cabrera, R., Shuster, J. J., Theriaque, D. W., Reed, A., Hemming, A. W., Liu, C., Crawford, J. M., et al. (2004) · Liver Transplantation · doi:10.1002/lt.20238 · Cited by 148
Oton, E., Bárcena, R., Planas, J. M. M., Cuervas‐Mons, V., Moreno‐Zamora, A., Barrios, C., García-Garzón, S., Moreno, A. M., Boullosa-Graña, E., Rubio-González, E., et al. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01470.x · Cited by 128
Cited by
EASL Recommendations on Treatment of Hepatitis C 2018
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.026 · Cited by 2,827
Self-citationEASL recommendations on treatment of hepatitis C: Final update of the series☆
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.08.018 · Cited by 1,252
Self-citationEASL Recommendations on Treatment of Hepatitis C 2015
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.025 · Cited by 1,156
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
(2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.023 · Cited by 1,088
EASL Clinical Practice Guidelines: Liver transplantation
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.006 · Cited by 1,082
Metadata
- Authors
- Berenguer, M., Palau, A., Aguilera, V., Rayón, J.-M., Juan, F. S., & Prieto, M.
- Venue
- American Journal of Transplantation
- Publisher
- Elsevier BV
- Published
- 2008-03
- Volume
- 8
- Issue
- 3
- Pages
- 679-687
- ISSN
- 1600-6135 (ISSN-L)
- OpenAlex
- W2160289288
- Cited by
- 283
- References
- 13
- FWCI
- 15.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Benefits of Antiviral Therapy in Patients with Recurrent Hepatitis C Following Liver Transplantation. https://app.cochat.ai/papers/10.1111/j.1600-6143.2007.02126.x
- The paper
- Berenguer, M., Palau, A., Aguilera, V., Rayón, J.-M., Juan, F. S., & Prieto, M. (2008). Clinical Benefits of Antiviral Therapy in Patients with Recurrent Hepatitis C Following Liver Transplantation. American Journal of Transplantation. https://doi.org/10.1111/j.1600-6143.2007.02126.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.